SCHEMBL25355953

SCHEMBL25355953

N[C@@H](CCOC1CCCCC1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.43
▸ GRIK1 P39086 3/20 0.41
▸ DPP7 Q9UHL4 1/20 0.40
▸ GRIN2D O15399 5/20 0.39
▸ GRIN3B O60391 5/20 0.39
▸ GRIN1 Q05586 5/20 0.39
▸ GRIN2A Q12879 5/20 0.39
▸ GRIN2B Q13224 5/20 0.39
▸ GRIN2C Q14957 5/20 0.39
▸ GRIN3A Q8TCU5 5/20 0.39
▸ SLC1A3 P43003 4/20 0.39
▸ SLC1A2 P43004 4/20 0.39
▸ SLC1A1 P43005 4/20 0.39
▸ GRIK2 Q13002 2/20 0.39
▸ GSR P00390 2/20 0.39
▸ GRM2 Q14416 2/20 0.39
▸ GRM8 O00222 1/20 0.39
▸ GRM6 O15303 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25355957 1.00 NPC1 (0.43) NPC1GRIK1DPP7GRIN2DGRIN3B
SCHEMBL25356903 0.98 GRIN2D (0.41) NPC1GRIK1GRIN2DGRIN3BGRIN1
SCHEMBL25356906 0.98 GRIN2D (0.41) NPC1GRIK1GRIN2DGRIN3BGRIN1
SCHEMBL25660419 0.91 GSR (0.43) GRIK1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL25661097 0.91 GSR (0.43) GRIK1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL25355141 0.83 GSR (0.37) GRIK1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL25355147 0.83 GSR (0.37) GRIK1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL724270 0.81 GRIK1 (0.44) GRIK1DPP7GRIN2DGRIN3BGRIN1
SCHEMBL3447889 0.81 GRIK1 (0.44) GRIK1DPP7GRIN2DGRIN3BGRIN1
SCHEMBL25662304 0.81 GRIK1 (0.44) GRIK1DPP7GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP NPC1 3981/4885GRIK1 3246/4885DPP7 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback